In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Adlumiz is a novel oral pharmaceutical agent utilized primarily in the managemen···【more】
Release date:2024-08-05Recommended:186
Fidaxomicin is a pharmacological agent specifically indicated for the treatment ···【more】
Release date:2024-07-30Recommended:253
Fidaxomicin is primarily employed for the management of Clostridium difficile-as···【more】
Release date:2024-07-30Recommended:214
Anamorelinis a medication utilized in the treatment of specific ailments, and li···【more】
Release date:2024-07-30Recommended:165
Fidaxomicin is a pharmaceutical for the treatment of difficile-associated diarrh···【more】
Release date:2024-07-30Recommended:268
fidaxomicin, a pharmacological agent renowned for its efficacy against Clostridi···【more】
Release date:2024-07-30Recommended:199
Fidaxomicin is a pharmaceutical agent specifically designed to combat infections···【more】
Release date:2024-07-30Recommended:178
Sotorasib, a targeted therapeutic agent for advanced non-small cell lung cancer ···【more】
Release date:2024-07-09Recommended:291
Sotorasib, also known as Lumakras, is a targeted drug designed for patients with···【more】
Release date:2024-07-09Recommended:257
Sotorasibas a targeted therapeutic agent, is hailed as a milestone advancement i···【more】
Release date:2024-07-09Recommended:263
Sotorasib is a targeted therapy for patients with advanced NSCLC with KRAS p.G12···【more】
Release date:2024-07-09Recommended:325
Sotorasib represents a groundbreaking targeted therapy that has exhibited remark···【more】
Release date:2024-07-09Recommended:271